List view / Grid view

Dr Kathleen Mulvaney (Assistant Professor the Fralin Biomedical Research Institute’s Cancer Research Center)

 

news

New drug combo targets PRMT5 to fight deadly cancers

Scientists at Virginia Tech’s Fralin Biomedical Research Institute have identified…

31 July 2025 | By

Scientists at Virginia Tech’s Fralin Biomedical Research Institute have identified a promising drug target – PRMT5 – that could make treatment-resistant lung, brain and pancreatic cancers more vulnerable to therapy.